These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 8208308

  • 1. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T, Greube A, Strauss S, Heineke D, Lehmann J, Rommelspacher H.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
    [Abstract] [Full Text] [Related]

  • 2. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 3. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
    Rommelspacher H, May T, Salewski B.
    Eur J Pharmacol; 1994 Jan 24; 252(1):51-9. PubMed ID: 8149995
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
    Pawlik M, Rommelspacher H.
    Eur J Pharmacol; 1988 Mar 01; 147(2):163-71. PubMed ID: 3366173
    [Abstract] [Full Text] [Related]

  • 5. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
    May T, Pawlik M, Rommelspacher H.
    J Neurochem; 1991 Feb 01; 56(2):500-8. PubMed ID: 1988553
    [Abstract] [Full Text] [Related]

  • 6. 1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
    May T.
    Neurosci Lett; 1993 Nov 12; 162(1-2):55-8. PubMed ID: 8121637
    [Abstract] [Full Text] [Related]

  • 7. [3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
    May T, Rommelspacher H, Pawlik M.
    J Neurochem; 1991 Feb 12; 56(2):490-9. PubMed ID: 1988552
    [Abstract] [Full Text] [Related]

  • 8. [3H]norharman ([3H]beta-carboline) binds reversibly and with high affinity to a specific binding site in rat liver.
    Greube A, Rommelspacher H.
    Neurochem Res; 1993 Sep 12; 18(9):1029-31. PubMed ID: 8232719
    [Abstract] [Full Text] [Related]

  • 9. The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.
    Stawowy P, Bonnet R, Rommelspacher H.
    Biochem Pharmacol; 1999 Mar 01; 57(5):511-20. PubMed ID: 9952314
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
    Hosseini AR, Jackman GP, King PR, Louis WJ, Gundlach AL.
    J Auton Nerv Syst; 1998 Oct 15; 72(2-3):129-36. PubMed ID: 9851561
    [Abstract] [Full Text] [Related]

  • 11. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee.
    Herraiz T, Chaparro C.
    Life Sci; 2006 Jan 18; 78(8):795-802. PubMed ID: 16139309
    [Abstract] [Full Text] [Related]

  • 12. Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
    Pawlik M, Kaulen P, Baumgarten HG, Rommelspacher H.
    J Chem Neuroanat; 1990 Jan 18; 3(1):19-24. PubMed ID: 2156525
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G, Gabilondo AM, Miralles A, Escriba PV, García-Sevilla JA.
    Br J Pharmacol; 1993 Mar 18; 108(3):597-603. PubMed ID: 8385528
    [Abstract] [Full Text] [Related]

  • 14. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR, Gundlach AL, Louis WJ.
    Ann N Y Acad Sci; 1999 Jun 21; 881():161-70. PubMed ID: 10415911
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
    Herraiz T.
    J Enzyme Inhib Med Chem; 2012 Dec 21; 27(6):810-7. PubMed ID: 21992679
    [Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
    Truman P, Grounds P, Brennan KA.
    Neurotoxicology; 2017 Mar 21; 59():22-26. PubMed ID: 28057462
    [Abstract] [Full Text] [Related]

  • 17. Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
    Maschauer S, Haller A, Riss PJ, Kuwert T, Prante O, Cumming P.
    J Neurochem; 2015 Dec 21; 135(5):908-17. PubMed ID: 26386360
    [Abstract] [Full Text] [Related]

  • 18. [Effects of harman and norharman on aflatoxin B1 and aminopyrine metabolism by phenobarbital and 3-methylcholanthrene-induced rat liver microsomes].
    Lin DX.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Jul 21; 26(4):209-12. PubMed ID: 1302193
    [Abstract] [Full Text] [Related]

  • 19. [3H]Harman labels selectively and with high affinity the active site of monoamine oxidase (EC 1.4.3.4) subtype A (MAO-A) in rat, marmoset, and pig.
    May T, Strauss S, Rommelspacher H.
    J Neural Transm Suppl; 1990 Jul 21; 32():93-102. PubMed ID: 2128516
    [Abstract] [Full Text] [Related]

  • 20. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1995 Feb 21; 114(4):837-45. PubMed ID: 7773544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.